Basel Biomed Symposium 2025
Am Freitag, 23. Mai 2025 feiern wir die Grundsteinlegung des Neubaus für das Departement Biomedizin der Universität Basel. Wir nutzen diesen Anlass, um das Basel Biomed Symposium zu lancieren.
Das Basel Biomed Symposium soll die wissenschaftliche Vernetzung, Kooperation und Innovation im Life-Science-Ökosystem Basel fördern. In vier Sessions wird das 1. Basel Biomed Symposium Wertschöpfungsketten der biomedizinischen Forschung von den biologischen Grundlagen bis zur klinischen Anwendung aufzeigen.
Programm – Stand 26. Februar 2025
Friday, May 23, 2025 – Morning 08.45 – 12:00
From Cell Biology to Cell and Tissue Engineering and Therapy
Chairs: Ivan Martin / Prisca Liberali | Speaker: Nina Khanna, University Hospital Basel; Heinz Läubli, University Hospital Basel; Prisca Liberali, FMI/D-BSSE; Matthias Lütolf, IHB/Roche; Ivan Martin, University of Basel, DBM; Sai Reddi, D-BSSE; Botond Roska, IOB; Jürg Steiger, University Hospital Basel; Stefanie Urlinger, Cimeio.
Digital Medicine and AI in Medicine
Chairs: Daniel Müller / Kirsten Taylor | Speaker: Philippe Cattin, University of Basel, DBE; Jens Eckstein, University Hospital Basel; Georg Holländer, BRCCH; Michael Moor, D-BSSE; Daniel Müller, D-BSSE; Kirsten Taylor, Roche; Jürg Utzinger, Swiss TPH; Judith Zaugg, University of Basel, DBM
Afternoon 13:30 – 17:00
From Molecular Pathways to Personalised Medicine and Cancer Therapy
Chairs: Primo Schär / Annette Luther | Speaker: Mohamed Bentires-Alj, University of Basel, DBM; Adrian Britschgi, pRED (tbc) / Roche; Abdullah Kahraman, FHNW; Niklaus Labhardt, University of Basel, DKF; Markus Lill, University of Basel, DPS; Annette Luther, Roche; Falko Schlottig, FHNW; Elisabetta Traggiai, Novartis; Walter Weber, University Hospital Basel
From Neuroscience to Neurology
Chairs: Alex Schier / Michaela Kneissel | Speaker: Silvia Arber, FMI, Biozentrum; Dominique De Quervain, University of Basel DBM, UPK; Urs Frey, UKBB; Christina Granziera, University of Basel DBE, University Hospital Basel; Michaela Kneissel, Novartis; Andreas Papassotiropoulos, University of Basel DBM, UPK; Peter Scheiffele, University of Basel, Biozentrum; Alex Schier, University of Basel, Biozentrum; Derya Shimshek, Novartis.
Scientific Board des Basel Biomed Symposium
- Prof. Dr. Primo Schär, Vice President for Research, University of Basel
- Prof. Dr. Alex Schier, Head Department Biozentrum, University of Basel
- Prof. Dr. Ivan Martin, Head Department of Biomedicine, University of Basel
- Prof. Dr. Jürg Steiger, Chief Medical Director, University Hospital
- Prof. Dr. Daniel Müller, Department BSSE, ETH Zürich
- Dr. Annette Luther, Hoffmann-La Roche
- Dr. Michaela Kneissel, Global Head Diseases of Aging and Regenerative medicine, Novartis
